BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2289535)

  • 21. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
    Cobb CS; Brown JA
    Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II receptor isoforms in the rat adrenal gland: studies with the selective subtype antagonists DuP 753 and CGP42112A.
    Montiel M; Barker S; Vinson GP; Jiménez E
    J Mol Endocrinol; 1993 Aug; 11(1):69-75. PubMed ID: 8240673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists.
    Leung KH; Smith RD; Pieter ; Timmermans BM; Chiu AT
    Neurosci Lett; 1991 Feb; 123(1):95-8. PubMed ID: 2062460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
    Boulay G; Servant G; Luong TT; Escher E; Guillemette G
    Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.
    Speth RC; Kim KH
    Biochem Biophys Res Commun; 1990 Jun; 169(3):997-1006. PubMed ID: 2194459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the presence of angiotensin II-type 1 receptors in brain.
    Wamsley JK; Herblin WF; Alburges ME; Hunt M
    Brain Res Bull; 1990 Sep; 25(3):397-400. PubMed ID: 2292036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor binding radiotracers for the angiotensin II receptor: radioiodinated [Sar1, Ile8]Angiotensin II.
    Gibson RE; Beauchamp HT; Fioravanti C; Brenner N; Burns HD
    Nucl Med Biol; 1994 May; 21(4):593-600. PubMed ID: 9234316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of angiotensin II receptor subtypes in rat and human kidney.
    Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
    Am J Physiol; 1992 Feb; 262(2 Pt 2):F236-40. PubMed ID: 1539685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
    Feuillan PP; Millan MA; Aguilera G
    Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells.
    Tallant EA; Diz DI; Khosla MC; Ferrario CM
    Hypertension; 1991 Jun; 17(6 Pt 2):1135-43. PubMed ID: 2045160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT; McCall DE; Aldrich PE; Timmermans PB
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1195-202. PubMed ID: 2244903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
    Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T
    J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human aortic smooth muscle cells containing angiotensin II type 1 receptors.
    Yazawa H; Iida-Kubota E; Honda K
    Jpn J Pharmacol; 1993 Aug; 62(4):339-43. PubMed ID: 8230860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of peptidase inhibitors on binding at angiotensin receptor subtypes in the rat brain.
    Saylor DL; Speth RC; Rowe BP
    Biochem Pharmacol; 1993 May; 45(10):2109-14. PubMed ID: 8512592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain.
    Gehlert DR; Gackenheimer SL; Schober DA
    Neuroscience; 1991; 44(2):501-14. PubMed ID: 1944896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
    Smith RD
    FEBS Lett; 1995 Oct; 373(3):199-202. PubMed ID: 7589465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo occupancy of angiotensin II subtype 1 receptors in rat renal medullary interstitial cells.
    Zhuo J; Alcorn D; McCausland J; Casley D; Mendelsohn FA
    Hypertension; 1994 Jun; 23(6 Pt 2):838-43. PubMed ID: 8206614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.